DailyIQ
Last updated 1 hour ago

IR·Ingersoll Rand Inc.

$.
+. (+.%)
High
$71.90
Open
$71.56
Market Cap
27.75B
52W High
$100.96
Low
$71.11
P. Close
$70.91
P/E
47.27
52W Low
$68.07
Fwd P/E
-
Mean Target
-
Technical Score (1D)
27
SELL
News Sentiment
47
MIXED
Ingersoll Rand (IR) is seeing optimistic price targets from Wall Street analysts, indicating potential upside. However, recent organic sales performance has raised concerns, suggesting that strategic adjustments or M&A may be needed to accelerate growth. Slower estimated sales growth and a lower return on capital also point to potential challenges for management in capitalizing on profitable opportunities. Investors will be watching for any strategic announcements or M&A activity that could address these growth concerns.
Earnings Summary
Ingersoll Rand Inc. is a global provider of essential technology solutions for air, fluid, energy, and medical applications, operating across diverse industries through its Industrial Technologies and Services, and Precision and Science Technologies segments. The company's broad portfolio includes compression systems, fluid transfer equipment, and precision dosing systems, distributed via direct sales and independent distributors. In its most recent reported quarter, Q1 2026, Ingersoll Rand reported an actual EPS of $0.77 against an estimate of $0.7402, and actual revenue of $1.847 billion against an estimate of $1.830 billion, indicating a beat on both metrics. This follows a Q4 2025 performance where actual EPS was $0.96, exceeding the estimate of $0.9296, and actual revenue of $2.091 billion surpassed the estimate of $2.100 billion, though the revenue estimate was missed slightly. The company has demonstrated a pattern of meeting or exceeding EPS expectations in recent quarters, with Q1 2026 and Q4 2025 both showing positive results relative to analyst forecasts. Looking at the historical trajectory, the company has shown a consistent ability to deliver on earnings, with Q4 2025 and Q1 2026 both reporting actual EPS above estimates. Recent news highlights that Ingersoll Rand's Q1 2026 results surpassed expectations, with EPS exceeding estimates by 4.76% and revenue by 1.15%, showing a 7.6% year-over-year revenue increase. Despite this positive performance, there are mixed analyst sentiments and price target adjustments, with some maintaining 'Outperform' or 'Buy' ratings while others suggest a more cautious near-term view. Investors will be watching for continued operational execution and management's commentary on future guidance and market outlook in the upcoming quarters, particularly in light of varied analyst perspectives and broader market rotations affecting industrial stocks.

EPS

EstBeatMiss
$0.68$0.76$0.84$0.92$1.00Q1'25Q2'25Q3'25Q4'25Q1'26
QtrEstActual+/−
Q1'26$0.74$0.77+4.0%
Q4'25$0.93$0.96+3.3%
Q3'25$0.86$0.86-0.3%
Q2'25$0.80$0.80+0.2%
Q1'25$0.74$0.72-2.3%

Revenue

EstBeatMiss
$1.7B$1.8B$1.9B$2.0B$2.2BQ1'25Q2'25Q3'25Q4'25Q1'26
QtrEstActual+/−
Q1'26$1.8B$1.8B+0.9%
Q4'25$2.1B$2.1B-0.4%
Q3'25 - $2.0B -
Q2'25 - $1.9B -
Q1'25 - $1.7B -

Market Data

IR Stock Snapshot

IR is currently trading at $71.55, giving Ingersoll Rand Inc. a market cap of 27.75B and a P/E ratio of 47.3. Today's range spans $71.11–$71.90, with shares opening at $71.56 and moving up $0.64 (0.9%) from the prior close. DailyIQ's technical score sits at 27/100 (SELL) with a news sentiment reading of 47/100.

Over the past year IR has traded between $68.07 and $100.96 - the current price is +5.1% off the 52-week low and -29.1% from the high.

IR is showing a SELL signal (27/100) with neutral sentiment (47/100). Price: $71.55 (near 52-week lows within $68.07–$100.96). (P/E: 47.3) At 27.75B in Industrials market cap, a bearish technical read accompanied by negative sentiment often marks the beginning of an earnings revision cycle downward - active managers trim before the revisions become consensus, compounding the selling pressure.

When a large-cap Industrials name with 27.75B in capitalization prints a SELL signal (27/100) alongside neutral news sentiment (47/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $71.55 (near 52-week lows in the $68.07–$100.96 range), the structural support levels are where that sponsorship question gets answered.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles
Loading latest news…